Niagen Bioscience
Antonia Zhou is the Chief Financial Officer at ChromaDex since June 2023, overseeing financial strategies for the bioscience company focused on healthy aging and nicotinamide adenine dinucleotide (NAD+). Prior to this role, Antonia served at Mattel, Inc. from October 2013 to May 2023, where responsibilities included directing corporate financial planning and analysis and managing investor relations, notably during significant corporate events such as acquisitions and executive transitions. Antonia began professional career as a Results Analyst at Capital Guardian Trust Company from June 2008 to September 2013, providing performance measurement and risk analysis for institutional clients. Educational background includes a Bachelor's Degree in Economics from Sun Yat-sen University - Lingnan (University) College and an MBA in Finance and Management from USC Marshall School of Business.
This person is not in any offices